NCT03607942View on ClinicalTrials.gov

Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides (HMOs) in Preterm Infants

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

October 30, 2020

Study Completion Date

November 30, 2022

Conditions
Premature Infant
Interventions
DIETARY_SUPPLEMENT

HMO supplement

HMO supplement will be given three times a day, not mixed with any feeding.

DIETARY_SUPPLEMENT

Placebo comparator

Control product without any HMOs. The Placebo Comparator will be matched to the experimental product in energy content.

Trial Locations (7)

13000

Hôpital Nord, Marseille

33000

CHU de Bordeaux - Hôpital des Enfants, Bordeaux

38043

Hôpital Couple Enfant, Grenoble

44093

Hôpital femme-maternité, Nantes

45100

CHR Orléans - Hôpital de la Source, Orléans

54035

Maternité Régionale Universitaire A. Pinard - CHRU Nancy, Nancy

64046

Centre Hospitalier de Pau, Pau

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT03607942 - Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides (HMOs) in Preterm Infants | Biotech Hunter | Biotech Hunter